NCT07089966

Brief Summary

This is a cluster randomized, stepped wedge implementation study to introduce HIV testing services (HTS) counselor-led PrEP care in public health clinics in Kenya.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30,000

participants targeted

Target at P75+ for not_applicable

Timeline
39mo left

Started Apr 2026

Longer than P75 for not_applicable

Geographic Reach
1 country

2 active sites

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress3%
Apr 2026Jun 2029

First Submitted

Initial submission to the registry

May 5, 2025

Completed
3 months until next milestone

First Posted

Study publicly available on registry

July 29, 2025

Completed
8 months until next milestone

Study Start

First participant enrolled

April 1, 2026

Completed
2.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2028

Expected
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2029

Last Updated

July 29, 2025

Status Verified

March 1, 2025

Enrollment Period

2.8 years

First QC Date

May 5, 2025

Last Update Submit

July 22, 2025

Conditions

Keywords

PrEPHIV Prevention

Outcome Measures

Primary Outcomes (3)

  • PrEP screening

    Using individual client-level data at clinics, compare proportion of clients completing PrEP eligibility screening in usual care (control) versus intervention time points

    Up to 42 months

  • PrEP initiation

    Using individual client-level data at clinics, compare PrEP initiation in usual care (control) versus intervention time points. PrEP initiation will be measured as the proportion of eligible clients starting PrEP use documented on ministry of health (MOH) tools.

    Up to 42 months

  • PrEP continuation

    Using individual client-level data at clinics, compare PrEP continuation in usual care (control) versus intervention time points. PrEP continuation among clients initiating PrEP will be determined by clinic visit attendance and pharmacy PrEP refill records obtained by abstraction of MOH clinic records.

    Up to 42 months

Study Arms (2)

Control (Usual care)

NO INTERVENTION

The control period (usual care) will be when the clinics are still implementing the usual care model, prior to implementing the intervention. Prior to launching the intervention, all facilities will have a baseline phase of 3 months. That time, in conjunction with other periods when the clinics are implementing usual care will serve as the control period.

HTS counselor-led PrEP care model

EXPERIMENTAL

During the intervention period, all core components of PrEP delivery - including HIV testing, eligibility assessment, dispensing, adherence counseling, and provision of refills will be conducted by existing facility HTS counselor as part of standard of care.

Other: HTS counselor-led PrEP care model

Interventions

PrEP delivery ,including HIV testing, eligibility assessment, dispensing, adherence counseling, and provision of refills, provided by an HTS counselor

Also known as: HTS-led PrEP
HTS counselor-led PrEP care model

Eligibility Criteria

Age15 Years+
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • ≥15 years of age
  • Accessing health services at participating public health facilities.
  • Not known to be living with HIV prior to the visit when their clinical data is first abstracted

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Kenyatta National Hospital

Kisumu, Kenya

Location

Kenyatta National Hospital

Siaya, Kenya

Location

MeSH Terms

Conditions

Acquired Immunodeficiency Syndrome

Condition Hierarchy (Ancestors)

HIV InfectionsBlood-Borne InfectionsCommunicable DiseasesInfectionsSexually Transmitted Diseases, ViralSexually Transmitted DiseasesLentivirus InfectionsRetroviridae InfectionsRNA Virus InfectionsVirus DiseasesSlow Virus DiseasesGenital DiseasesUrogenital DiseasesImmunologic Deficiency SyndromesImmune System Diseases

Study Officials

  • Kenneth Mugwanya, MBChB, MS, PhD

    University of Washington

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Laura Drown

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
PREVENTION
Intervention Model
SINGLE GROUP
Model Details: Stepped-wedge cluster randomized trial of 20 public health clinics implementing the intervention of HTS counselor-led PrEP care
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor: School of Medicine, Global Health

Study Record Dates

First Submitted

May 5, 2025

First Posted

July 29, 2025

Study Start

April 1, 2026

Primary Completion (Estimated)

December 31, 2028

Study Completion (Estimated)

June 30, 2029

Last Updated

July 29, 2025

Record last verified: 2025-03

Data Sharing

IPD Sharing
Will not share

Locations